May 10, 2026 – A woman who suffered from three life-threatening autoimmune diseases returned to an almost normal life after cell therapy apparently led to a “reset” of her immune system. Chimeric Antigen Receptor T‑cell (CAR‑T) therapy, a breakthrough treatment that has already transformed outcomes for patients with certain blood cancers, now shows significant potential in…
January 31, 2024 – Until recently, most patients with lymphoma who did not respond well to chemotherapy had a grim diagnosis, measured in months. However, new research into CAR-T therapy is offering new hope to these patients, with excellent long-term results. Chimeric antigen receptor T-cell (CAR-T) therapy was developed more than a decade ago, and…
January 30, 2023 – Follicular lymphoma is a slow-growing type of cancer that may appear in the bone marrow, lymph nodes, or other organs. CAR T-Cell therapy – a revolutionary blood cancer treatment, is one of many in the arsenal of cancer therapies offered at Rambam Health Care Campus (Rambam) in Haifa, Israel. Rambam is…
